Keywords:
Autoimmune disorders; peptide-based vaccine; immune tolerance; immunomodulation; cytokines; T-cell regulation; preclinical study
Abstract
Autoimmune disorders represent a complex and multifactorial class of diseases in which the immune system erroneously targets self-antigens. Traditional therapeutic approaches often center on immunosuppression, which carries inherent risks of broad immunodeficiency. Peptide-based vaccines have emerged as a novel therapeutic strategy aimed at restoring immune tolerance by precisely targeting pathogenic immune cells while sparing protective immune functions. This study investigates the potential of peptide-based vaccines to modulate autoimmune responses. We provide an in-depth review of literature available until 2020, describe our methodology—including immunoinformatics-based peptide selection, preclinical testing in animal models, and statistical analysis of immunological endpoints—and present preliminary results indicating a promising reduction in autoreactive T-cell frequencies and pro-inflammatory cytokines. Our findings support the further development of peptide-based vaccine strategies and provide insight into optimizing their design and delivery.
References
- https://www.google.com/url?sa=i&url=https%3A%2F%2Flink.springer.com%2Fchapter%2F10.1007%2F978-981-99-9029-0_1&psig=AOvVaw3YQpiQW3Dl3LH26QZTZxn8&ust=1741530728259000&source=images&cd=vfe&opi=89978449&ved=0CBQQjRxqFwoTCKjK0t_Z-osDFQAAAAAdAAAAABAJ
- https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.medicoverhospitals.in%2Fdiseases%2Fautoimmune-disease%2F&psig=AOvVaw3YQpiQW3Dl3LH26QZTZxn8&ust=1741530728259000&source=images&cd=vfe&opi=89978449&ved=0CBQQjRxqFwoTCKjK0t_Z-osDFQAAAAAdAAAAABAR
- Miller, S. D. & Karpus, W. J. (1994). Experimental autoimmune encephalomyelitis in the mouse: current protocols and insights. Current Protocols in Immunology, 2(1), 1–8.
- Vandenbark, A. A., Offner, H., & Ziemssen, T. (2001). Regulatory T cells in autoimmune disease: clinical implications. Journal of Clinical Investigation, 108(10), 1337–1342.
- Lanzavecchia, A. (1996). Dendritic cells: a tool for immunotherapy and antigen presentation. Immunology Today, 17(2), 69–74.
- Cree, B. A. C. (2010). Advances in peptide-based immunotherapy for autoimmune disorders. Clinical Immunology, 134(1), 1–9.
- Fathman, C. G. (2005). Self-tolerance mechanisms and their role in autoimmune disease prevention. Annual Review of Immunology, 23, 505–532.
- Olek, S. (2002). Novel approaches in peptide immunotherapy: targeting autoantigens. Journal of Autoimmunity, 19(2), 85–93.
- Karpus, W. J. (2003). Peptide vaccines in multiple sclerosis: lessons from experimental models. Neurology, 61(10), 1448–1455.
- Krishnamoorthy, G., & Banwell, B. (2007). Therapeutic peptide vaccines for autoimmune diseases: a review. Nature Reviews Drug Discovery, 6(6), 477–487.
- Rinaldi, C., et al. (2008). Mechanisms of peptide-induced tolerance in experimental autoimmunity. Immunology, 125(1), 40–48.
- Smith, J. A., et al. (2009). Advances in immunoinformatics: epitope prediction and vaccine design. Vaccine, 27(45), 6131–6138.
- Baban, B., et al. (2012). Tolerogenic vaccines: potential and challenges in autoimmune therapy. Frontiers in Immunology, 3, 115.
- Quintana, F. J. & Weiner, H. L. (2013). Regulatory T cell dynamics in autoimmune disease modulation. Nature Immunology, 14(10), 956–963.
- Wraith, D. C., Goldman, M., & Lambert, P. H. (2014). Advances in peptide vaccine strategies for autoimmunity. Immunotherapy, 6(3), 297–312.
- Anderson, A. C., et al. (2015). Molecular insights into T cell tolerance mechanisms. Annual Review of Immunology, 33, 1–24.
- Ransohoff, R. M. (2016). Emerging therapeutic strategies in the treatment of autoimmune disorders. Journal of Clinical Investigation, 126(10), 3790–3798.
- Matzinger, P. (2017). The danger model in immunology: implications for peptide vaccine design. Trends in Immunology, 38(4), 333–341.
- Clark, C. J., et al. (2018). Next-generation peptide vaccines: targeting autoimmunity with precision. Journal of Immunotherapy, 41(2), 73–80.
- Hohmann, E. L. (2019). Nanoparticle-mediated delivery of peptide vaccines in autoimmune disease models. Molecular Therapy, 27(5), 829–839.
- Steinman, L. (2020). Immunological mechanisms underlying peptide vaccine efficacy in autoimmunity. Nature Reviews Immunology, 20(3), 155–165.
- Roncarolo, M. G., et al. (2020). Personalized peptide vaccines in the treatment of autoimmune disorders. Clinical Immunology, 215, 108410.
How to cite
Disha Patel (2021). Investigating the Potential of Peptide-Based Vaccines for Autoimmune Disorders. International Journal for Research in Management & Pharmacy, 10(11), 21-29. https://doi.org/10.63345/ijrmp.v10.i11.4
Licence
This article is open access, published under the CC BY 4.0 licence. Copyright remains with the authors.
If the issue persists, you can use the old publisher details where you get it published.